Moreover, analyses of Kaplan–Meier curves revealed glioma patients with high expression and low methylation of NCOA4 had better overall survival (OS) than those with low expression and high methylation of NCOA4 (P < 0.01) (Fig. 1C). The gene discussed is NCOA4; the disease is glioma.